المؤلفون: Altorki TA; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia., Abdulal RH; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia., Suliman BA; Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia., Aljeraisi TM; Otorhinolaryngology, Head and Neck Surgery Department, Faculty of Medicine, Taibah University, Madinah, Saudi Arabia., Alsharef A; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia., Abdulaal WH; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia., Alfaleh MA; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Algaissi AA; Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia., Alhabbab RY; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia., Ozbak H; Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia., Eid HM; Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia., Almutawif YA; Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia., Li X; Centre for Oncology and Regulatory Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada., Al-Rabia MW; Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia., Zhang Q; Academic and Research Departments, Section of Immunology, School of Biosciences and Medicine University of Surrey, Surrey, United Kingdom., Mahmoud AB; Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.; Health and Life Research Center, Taibah University, Madinah, Saudi Arabia., Mahallawi WH; Medical Laboratory Technology Department, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia., Hashem AM; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

المصدر: Frontiers in immunology [Front Immunol] 2023 Dec 11; Vol. 14, pp. 1291534. Date of Electronic Publication: 2023 Dec 11 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Vaccines*, Adult ; Child ; Humans ; Immunity, Humoral ; Palatine Tonsil ; SARS-CoV-2 ; Immunoglobulin G ; Antibodies, Neutralizing

المؤلفون: Algaissi AA; Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia; Medical Research Center, Jazan University, Jazan, Saudi Arabia., Alharbi NK; Department of Infectious Disease Research, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Hassanain M; Department of Surgery, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia., Hashem AM; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Vaccines and Immunnotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: amhashem@kau.edu.sa.

المصدر: Journal of infection and public health [J Infect Public Health] 2020 Jun; Vol. 13 (6), pp. 834-838. Date of Electronic Publication: 2020 May 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X (Electronic) Linking ISSN: 18760341 NLM ISO Abbreviation: J Infect Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Middle East Respiratory Syndrome Coronavirus*, Communicable Disease Control/*methods , Coronavirus Infections/*prevention & control , Pandemics/*prevention & control , Pneumonia, Viral/*prevention & control, Animals ; Betacoronavirus ; COVID-19 ; Camelus/virology ; Coronavirus Infections/epidemiology ; Disease Transmission, Infectious/prevention & control ; Humans ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Saudi Arabia/epidemiology ; Travel ; Zoonoses/epidemiology ; Zoonoses/virology

المؤلفون: Hashem AM; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Vaccines and Immunnotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: amhashem@kau.edu.sa., Alghamdi BS; Department of Physiology, Neuroscience Unit, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Pre-Clinical Research Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: basalghamdi@kau.edu.sa., Algaissi AA; Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia; Medical Research Center, Jazan University, Jazan, Saudi Arabia. Electronic address: AAlgaissi@jazanu.edu.sa., Alshehri FS; Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Electronic address: fsshehri@uqu.edu.sa., Bukhari A; Department of Medicine, Faculty of Medicine, Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia. Electronic address: aibukhari@imamu.edu.sa., Alfaleh MA; Vaccines and Immunnotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Faculty of Pharmacy; King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: maalfaleh@kau.edu.sa., Memish ZA; King Saud Medical City, Research & Innovation Center, Ministry of Health, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: zmemish@yahoo.com.

المصدر: Travel medicine and infectious disease [Travel Med Infect Dis] 2020 May - Jun; Vol. 35, pp. 101735. Date of Electronic Publication: 2020 May 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 101230758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-0442 (Electronic) Linking ISSN: 14778939 NLM ISO Abbreviation: Travel Med Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials/*therapeutic use , Antiviral Agents/*therapeutic use , Betacoronavirus/*physiology , Coronavirus Infections/*drug therapy , Hydroxychloroquine/*therapeutic use , Pneumonia, Viral/*drug therapy, Animals ; Antimalarials/adverse effects ; Antimalarials/blood ; Antimalarials/pharmacokinetics ; Antiviral Agents/blood ; Antiviral Agents/pharmacokinetics ; Betacoronavirus/drug effects ; Biological Availability ; COVID-19 ; Coronavirus Infections/virology ; Half-Life ; Humans ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/blood ; Hydroxychloroquine/pharmacokinetics ; Pandemics ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Treatment Outcome ; Virus Internalization/drug effects ; Virus Replication/drug effects ; COVID-19 Drug Treatment